AI
Thursday, May 11, 2006 5:58:06 PM
I have just finished listening to the C/C and like the new developments. Isn't Lilly's Alimta expected to cross 1B$ sales annually? Looks like your interest in Coly is getting bigger
The phase-2 trial of PF-3512676 in Breast cancer is an int. development for me. I guess Pfizer will start more trials in other indications after P3 results in NSCLC.
Why do you want coley's employees to work weekends when pfizer is doing the hard work...
Praveen
The phase-2 trial of PF-3512676 in Breast cancer is an int. development for me. I guess Pfizer will start more trials in other indications after P3 results in NSCLC.
Why do you want coley's employees to work weekends when pfizer is doing the hard work...
Praveen
The power of imagination makes us Infinite
Trade Smarter with Thousands
Leverage decades of market experience shared openly.
